Sinus Node Dysfunction
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Rhythm PharmaceuticalsBOSTON, MA
2 programsEvidence based guidelines and toolsN/A1 trial
Pacemaker lower rate settingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiotronikSolia CSP S lead
Rhythm PharmaceuticalsPacemaker lower rate setting
Rhythm PharmaceuticalsEvidence based guidelines and tools
Clinical Trials (3)
Total enrollment: 1,607 patients across 3 trials
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
Start: Dec 2024Est. completion: Jun 2026192 patients
N/AActive Not Recruiting
Allometric-Pace Study
Start: Mar 2023Est. completion: Jan 202573 patients
N/ACompleted
Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)
Start: Jul 2012Est. completion: Jan 20191,342 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space